Acute poisonings treated in hospitals in Oslo: A one-year prospective study (II): Clinical outcome

References

• Jones AL, Volans G. Management of self poisoning. BMJ 1999; 319: 1414–1417
   PubMed Web of Science ®Google Scholar
• Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard OR. Clinical course in acute self-poisonings: A prospective study of 1125 consecutively hospitalised adults. Hum Toxicol 1984; 3: 107–116
   PubMedGoogle Scholar
• Rygnestad T, Fagerhaug O. Acute deliberate self-poisonings in the area of Trondheim, 1978–2002. Tidsskr Nor Laegeforen 2004; 124: 2736–2739
   PubMedGoogle Scholar
• Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985–1997: Trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 228–234
   PubMed Web of Science ®Google Scholar
• Staikowsky F, Theil F, Mercadier P, Candella S, Benais JP. Change in profile of acute self drug-poisonings over a 10-year period. Hum Exp Toxicol 2004; 23: 507–511
   PubMed Web of Science ®Google Scholar
• Lockhart SP, Baron JH. Changing ethnic and social characteristics of patients admitted for self-poisoning in West London during 1971/2 and 1983/4. J R Soc Med 1987; 80: 145–148
   PubMed Web of Science ®Google Scholar
• Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard OR. A prospective study of 1212 cases of acute poisoning: General epidemiology. Hum Toxicol 1984; 3: 93–106
   PubMedGoogle Scholar
• Bateman DN, Bain M, Gorman D, Murphy D. Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s. QJM 2003; 96: 125–132
   PubMed Web of Science ®Google Scholar
• Burillo-Putze G, Munne P, Duenas A, Pinillos MA, Naveiro JM, Cobo J, Alonso J. National multicentre study of acute intoxication in emergency departments of Spain. Eur J Emerg Med 2003; 10: 101–104
   PubMed Web of Science ®Google Scholar
• Van Sassenbroeck DK, Calle PA, Rousseau FM, Verstraete AG, Belpaire FM, Monsieurs KG, Haentjens R, Allonsius J, Van BJ, Haenen W, Buylaert WA. Medical problems related to recreational drug use at nocturnal dance parties. Eur J Emerg Med 2003; 10: 302–308
   PubMed Web of Science ®Google Scholar
• Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol 2002; 40: 129–135
   PubMed Web of Science ®Google Scholar
• Snead OC, III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005; 352: 2721–2732
   PubMed Web of Science ®Google Scholar
• Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: Epidemiology, prevention and costs to the health-care system. QJM 2002; 95: 609–619
   PubMed Web of Science ®Google Scholar
• D'Mello DA, Finkbeiner DS, Kocher KN. The cost of antidepressant overdose. Gen Hosp Psychiatry 1995; 17: 454–455
   PubMed Web of Science ®Google Scholar
• Hovda KE, Bjornaas MA, Skog K, Opdahl A, Drottning P, Ekeberg O, Jacobsen D. Acute poisonings treated in hospital in Oslo: A one-year prospective study (I): Pattern of poisoning. clin Toxicol 2007
   Web of Science ®Google Scholar
• Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004; 11: 19–23
   PubMed Web of Science ®Google Scholar
• Hatzitolios AI, Sion ML, Eleftheriadis NP, Toulis E, Efstratiadis G, Vartzopoulos D, Ziakas AG. Parasuicidal poisoning treated in a Greek medical ward: epidemiology and clinical experience. Hum Exp Toxicol 2001; 20: 611–617
   PubMed Web of Science ®Google Scholar
• Cienki JJ, Burkhart KK, Donovan JW. Zopiclone overdose responsive to flumazenil. Clin Toxicol 2005; 43: 385–386
   Web of Science ®Google Scholar
• Barnett R, Grace M, Boothe P, Latozek K, Neal C, Legatt D, Finegan BA. Flumazenil in drug overdose: Randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med 1999; 27: 78–81
   PubMed Web of Science ®Google Scholar
• Longmire AW, Seger DL. Topics in clinical pharmacology: Flumazenil, a benzodiazepine antagonist. Am J Med Sci 1993; 306: 49–52
   PubMed Web of Science ®Google Scholar
• Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E, Niv D. Use of flumazenil in the treatment of drug overdose: A double-blind and open clinical study in 110 patients. Crit Care Med 1996; 24: 199–206
   PubMed Web of Science ®Google Scholar
• Dargan PI, Jones AL. Management of paracetamol poisoning. Trends Pharmacol Sci 2003; 24: 154–157
   PubMed Web of Science ®Google Scholar
• Newton RW. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA 1975; 231: 941–943
   PubMed Web of Science ®Google Scholar
• Vale JA. Position statement: Gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35: 711–719
   PubMed Web of Science ®Google Scholar
• Lamminpaa A, Riihimaki V, Vilska J. Hospitalizations due to poisonings in Finland. J Clin Epidemiol 1993; 46: 47–55
   PubMed Web of Science ®Google Scholar
• Tagwireyi D, Ball DE, Nhachi CF. Poisoning in Zimbabwe: A survey of eight major referral hospitals. J Appl Toxicol 2002; 22: 99–105
   PubMed Web of Science ®Google Scholar
• Bruyndonckx RB, Meulemans AI, Sabbe MB, Kumar AA, Delooz HH. Fatal intentional poisoning cases admitted to the University Hospitals of Leuven, Belgium from 1993 to 1996. Eur J Emerg Med 2002; 9: 238–243
   PubMedGoogle Scholar
• Nice A, Leikin JB, Maturen A, Madsen-Konczyk LJ, Zell M, Hryhorczuk DO. Toxidrome recognition to improve efficiency of emergency urine drug screens. Ann Emerg Med 1988; 17: 676–680
   PubMed Web of Science ®Google Scholar
• Bjornaas MA, Hovda KE, Mikalsen H, Andrew E, Rudberg N, Ekeberg O, Jacobsen D. Clinical vs. laboratory identification of drugs of abuse in patients admitted for acute poisoning. Clin Toxicol 2006; 44: 127–134
   Web of Science ®Google Scholar